These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21549322)

  • 21. Stem cell therapy in spinal cord injuries: current concepts.
    Chhabra HS
    J Assoc Physicians India; 2012 May; 60 Suppl():30-3. PubMed ID: 23155794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Informed consent: is it always necessary?
    Parvizi J; Chakravarty R; Og B; Rodriguez-Paez A
    Injury; 2008 Jun; 39(6):651-5. PubMed ID: 18502422
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The informed consent process in cancer research studies.
    Coleman DA
    Hawaii Med J; 2002 Oct; 61(10):235-6. PubMed ID: 12491765
    [No Abstract]   [Full Text] [Related]  

  • 24. Transplantation of human embryonic stem cell-derived oligodendrocyte progenitors into rat spinal cord injuries does not cause harm.
    Cloutier F; Siegenthaler MM; Nistor G; Keirstead HS
    Regen Med; 2006 Jul; 1(4):469-79. PubMed ID: 17465839
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elements of style: consent form language and the therapeutic misconception in phase 1 gene transfer trials.
    Kimmelman J; Levenstadt A
    Hum Gene Ther; 2005 Apr; 16(4):502-8. PubMed ID: 15871681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transplantation of adult rat spinal cord stem/progenitor cells for spinal cord injury.
    Parr AM; Kulbatski I; Tator CH
    J Neurotrauma; 2007 May; 24(5):835-45. PubMed ID: 17518538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Spinal cord regeneration: moving tentatively towards new perspectives.
    Jones DG; Anderson ER; Galvin KA
    NeuroRehabilitation; 2003; 18(4):339-51. PubMed ID: 14757930
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The International Xenotransplantation Association consensus statement on conditions for undertaking clinical trials of porcine islet products in type 1 diabetes--chapter 7: Informed consent and xenotransplantation clinical trials.
    Vanderpool HY
    Xenotransplantation; 2009; 16(4):255-62. PubMed ID: 19799766
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between fetal spinal-cord- and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury.
    Watanabe K; Nakamura M; Iwanami A; Fujita Y; Kanemura Y; Toyama Y; Okano H
    Dev Neurosci; 2004; 26(2-4):275-87. PubMed ID: 15711067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Informed consent in clinical research in France: assessment and factors associated with therapeutic misconception.
    Durand-Zaleski IS; Alberti C; Durieux P; Duval X; Gottot S; Ravaud P; Gainotti S; Vincent-Genod C; Moreau D; Amiel P
    J Med Ethics; 2008 Sep; 34(9):e16. PubMed ID: 18757616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and possible outcome assessment of autologous Schwann cell and bone marrow mesenchymal stromal cell co-transplantation for treatment of patients with chronic spinal cord injury.
    Yazdani SO; Hafizi M; Zali AR; Atashi A; Ashrafi F; Seddighi AS; Soleimani M
    Cytotherapy; 2013 Jul; 15(7):782-91. PubMed ID: 23731761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multipotent embryonic spinal cord stem cells expanded by endothelial factors and Shh/RA promote functional recovery after spinal cord injury.
    Lowry N; Goderie SK; Adamo M; Lederman P; Charniga C; Gill J; Silver J; Temple S
    Exp Neurol; 2008 Feb; 209(2):510-22. PubMed ID: 18029281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stem cells for the treatment of spinal cord injury.
    Coutts M; Keirstead HS
    Exp Neurol; 2008 Feb; 209(2):368-77. PubMed ID: 17950280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chitosan channels containing spinal cord-derived stem/progenitor cells for repair of subacute spinal cord injury in the rat.
    Bozkurt G; Mothe AJ; Zahir T; Kim H; Shoichet MS; Tator CH
    Neurosurgery; 2010 Dec; 67(6):1733-44. PubMed ID: 21107205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluating the first-in-human clinical trial of a human embryonic stem cell-based therapy.
    Chapman AR; Scala CC
    Kennedy Inst Ethics J; 2012 Sep; 22(3):243-61. PubMed ID: 23285793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Informed consent: views from Karachi.
    Jafarey A
    East Mediterr Health J; 2006; 12 Suppl 1():S50-5. PubMed ID: 17037689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decision-making in stem cell trials for spinal cord injury: the role of networks and peers.
    Eijkholt M; Kwon BK; Mizgalewicz A; Illes J
    Regen Med; 2012 Jul; 7(4):513-22. PubMed ID: 22817625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Number-8-wire ethics: a New Zealand ethics committee's response to lengthy international clinical trial information sheets.
    Tolich M; Hapuku J
    N Z Med J; 2009 Apr; 122(1293):3567. PubMed ID: 19448792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat.
    Kuh SU; Cho YE; Yoon DH; Kim KN; Ha Y
    Acta Neurochir (Wien); 2005 Sep; 147(9):985-92; discussion 992. PubMed ID: 16010451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoring function after spinal cord injury: towards clinical translation of experimental strategies.
    Ramer LM; Ramer MS; Bradbury EJ
    Lancet Neurol; 2014 Dec; 13(12):1241-56. PubMed ID: 25453463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.